Cipher Pharmaceuticals announced it has acquired three products from Astion Pharma that are focused on inflammatory dermatological diseases. With an upfront payment of $6 million (Canadian) to Astion, ...
MISSISSAUGA, ON, Nov. 7, 2018 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced its financial and operating results for the three and nine months ended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback